Lazard Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.39M | Buy |
16,280
+6,128
| +60% | +$2.09M | 0.01% | 546 |
|
|
2025
Q4 | $4.04M | Buy |
10,152
+401
| +4% | +$177K | 0.01% | 615 |
|
|
2025
Q3 | $4.45M | Buy |
9,751
+2,001
| +26% | +$815K | 0.01% | 609 |
|
|
2025
Q2 | $2.53M | Sell |
7,750
-4,138
| -35% | -$1.15M | ﹤0.01% | 929 |
|
|
2025
Q1 | $3.21M | Sell |
11,888
-12,306
| -51% | -$3.16M | ﹤0.01% | 820 |
|
|
2024
Q4 | $5.69M | Buy |
24,194
+4,315
| +22% | +$1.13M | 0.01% | 606 |
|
|
2024
Q3 | $5.47M | Sell |
19,879
-10,926
| -35% | -$2.84M | 0.01% | 611 |
|
|
2024
Q2 | $7.48M | Buy |
30,805
+27,198
| +754% | +$4.29M | 0.01% | 575 |
|
|
2024
Q1 | $538K | Sell |
3,607
-15,897
| -82% | -$2.65M | ﹤0.01% | 1041 |
|
|
2023
Q4 | $3.73M | Buy |
19,504
+3,673
| +23% | +$626K | ﹤0.01% | 740 |
|
|
2023
Q3 | $2.8M | Buy |
15,831
+14,892
| +1,586% | +$2.84M | ﹤0.01% | 813 |
|
|
2023
Q2 | $177K | Buy |
939
+350
| +59% | +$69.4K | ﹤0.01% | 1380 |
|
|
2023
Q1 | $117K | Buy |
589
+99
| +20% | +$20.8K | ﹤0.01% | 1470 |
|
|
2022
Q4 | $116K | Sell |
490
-59,589
| -99% | -$12.7M | ﹤0.01% | 1471 |
|
|
2022
Q3 | $12M | Buy |
60,079
+59,349
| +8,130% | +$11.3M | 0.02% | 527 |
|
|
2022
Q2 | $105K | Sell |
730
-335
| -31% | -$47.5K | ﹤0.01% | 1488 |
|
|
2022
Q1 | $173K | Buy |
1,065
+342
| +47% | +$52.1K | ﹤0.01% | 1281 |
|
|
2021
Q4 | $122K | Sell |
723
-1,037
| -59% | -$193K | ﹤0.01% | 1386 |
|
|
2021
Q3 | $332K | Sell |
1,760
-185
| -10% | -$34.7K | ﹤0.01% | 1226 |
|
|
2021
Q2 | $328K | Buy |
1,945
+890
| +84% | +$130K | ﹤0.01% | 1140 |
|
|
2021
Q1 | $148K | Buy |
1,055
+439
| +71% | +$66.1K | ﹤0.01% | 1146 |
|
|
2020
Q4 | $80K | Buy |
616
+18
| +3% | +$2.4K | ﹤0.01% | 1233 |
|
|
2020
Q3 | $87K | Sell |
598
-2,653
| -82% | -$377K | ﹤0.01% | 1044 |
|
|
2020
Q2 | $481K | Buy |
3,251
+2,065
| +174% | +$278K | ﹤0.01% | 819 |
|
|
2020
Q1 | $129K | Buy |
1,186
+925
| +354% | +$107K | ﹤0.01% | 960 |
|
|
2019
Q4 | $30K | Buy |
261
+69
| +36% | +$6.88K | ﹤0.01% | 1153 |
|
|
2019
Q3 | $15K | Buy |
+192
| New | +$15.2K | ﹤0.01% | 1145 |
|
|
2018
Q3 | – | Sell |
-6,228
| Closed | -$613K | – | 1045 |
|
|
2018
Q2 | $613K | Hold |
6,228
| – | – | ﹤0.01% | 764 |
|
|
2018
Q1 | $741K | Buy |
6,228
+471
| +8% | +$60.7K | ﹤0.01% | 739 |
|
|
2017
Q4 | $730K | Buy |
+5,757
| New | +$723K | ﹤0.01% | 728 |
|
Other funds holding ALNY
VPM
VCM
